Showing results (71-80 of 206) with videos related to
Sort By:
Pageof 21
Experimental and Clinical Psychopharmacology|November 23, 2006
Cognitive and subjective acute dose effects of intramuscular ketamine in healthy adultsMichelle R Lofwall, Roland R Griffiths, Miriam Z MintzerJournal of Community Psychology|March 17, 2023
Facilitating factors and barriers for use of medications to treat opioid use disorder (MOUD) among justice-involved individuals in rural AppalachiaMichele Staton, Erika Pike, Martha Tillson, et al.Substance Abuse|July 12, 2019
Adoption of the 275-patient buprenorphine treatment waiver for treating opioid use disorder: A state-level longitudinal analysisHannah K Knudsen, Lewei Allison Lin, Michelle R LofwallJournal of Addiction Medicine|September 26, 2018
Substance Use Disorder Assessment, Diagnosis, and Management for Patients Hospitalized With Severe Infections Due to Injection Drug UseCrystal Jicha, David Saxon, Michelle R Lofwall, et al.JAMA Psychiatry|June 28, 2017
Effect of Buprenorphine Weekly Depot (CAM2038) and Hydromorphone Blockade in Individuals With Opioid Use Disorder: A Randomized Clinical TrialSharon L Walsh, Sandra D Comer, Michelle R Lofwall, et al.Addiction Biology|June 27, 2019
A randomized, double-blind, placebo-controlled study of the kappa opioid receptor antagonist, CERC-501, in a human laboratory model of smoking behaviorJermaine D Jones, Shanna Babalonis, Ronald Marcus, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 11, 2020
Therapeutic potential of opioid/cannabinoid combinations in humans: Review of the evidenceShanna Babalonis, Sharon L WalshDrug and Alcohol Dependence|May 10, 2003
The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinicSharon L Walsh, Thomas EissenbergJAMA Internal Medicine|May 26, 2018
Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder: A Randomized Clinical TrialMichelle R Lofwall, Sharon L Walsh, Edward V Nunes, et al.Current Topics in Behavioral Neurosciences|July 1, 2016
The Abuse Potential of Prescription Opioids in Humans-Closing in on the First Century of ResearchSharon L Walsh, Shanna BabalonisPageof 21